The chemical class termed AADACL1 Activators encompasses a range of compounds that, while not directly interacting with Arylacetamide Deacetylase Like 1 (AADACL1), are theorized to modulate its activity indirectly through their influence on lipid metabolism and related cellular pathways. AADACL1, known for its role in lipid metabolism, may be affected by changes in the lipid profile within cells, which these compounds can induce. This class includes agents such as fibrates (e.g., Fenofibrate, Clofibrate, Gemfibrozil), nicotinic acid, and various statins (e.g., Fluvastatin, Pravastatin, Lovastatin), each known for their role in regulating lipid levels. The proposed mechanism by which these compounds might influence AADACL1 is through their impact on lipid metabolism pathways, which are integral to AADACL1's function. For example, fibrates, which are used to alter lipid profiles, could create a cellular environment that indirectly affects the activity of AADACL1 by changing the concentration or types of lipid substrates available to the enzyme. Similarly, statins, by modulating cholesterol synthesis, might impact lipid-related pathways and thus potentially influence AADACL1 activity.
In addition to lipid-regulating agents, this class also includes compounds like Pioglitazone and Rosiglitazone, members of the thiazolidinedione class, known to affect lipid metabolism. These compounds, along with agents like Omega-3 Fatty Acids and Retinoic Acid, which are involved in various aspects of cell regulation and gene expression, could alter cellular processes in a way that might indirectly modulate AADACL1 activity. The indirect activation of AADACL1 by these compounds highlights the complex nature of enzyme regulation within the cell, where changes in metabolic pathways and substrate availability can have downstream effects on enzyme activity. This interplay underscores the intricacies of cellular metabolism, where alterations in one pathway can ripple through the network, impacting enzymes like AADACL1 that are integral to these processes. Understanding the influence of these activators on AADACL1 is key to comprehending the broader regulatory mechanisms governing lipid metabolism and the potential modulation of this enzyme in response to changes in cellular lipid dynamics.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
A lipid-regulating agent that can influence lipid metabolism pathways potentially linked to AADACL | ||||||
Clofibrate | 637-07-0 | sc-200721 | 1 g | $33.00 | ||
An older lipid-lowering drug, potentially affecting lipid metabolism and indirectly impacting AADACL1 activity. | ||||||
Gemfibrozil | 25812-30-0 | sc-204764 sc-204764A | 5 g 25 g | $66.00 $267.00 | 2 | |
A fibrate agent in research that can influence lipid metabolism, potentially affecting AADACL | ||||||
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | $62.00 $124.00 | 1 | |
Influences lipid metabolism, possibly impacting pathways related to AADACL1 activity. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
A thiazolidinedione that can affect lipid metabolism, possibly impacting AADACL | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Another thiazolidinedione, potentially affecting lipid-related pathways involving AADACL | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Involved in gene expression and cellular differentiation, potentially affecting AADACL | ||||||
Fluvastatin | 93957-54-1 | sc-279169 | 50 mg | $250.00 | ||
A statin that can influence cholesterol metabolism, potentially impacting AADACL | ||||||
Pravastatin | 81093-37-0 | sc-222188 | 50 mg | $408.00 | 1 | |
Another statin, potentially affecting lipid-related pathways involving AADACL | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $29.00 $90.00 $339.00 | 12 | |
A statin that may influence lipid metabolism pathways related to AADACL | ||||||